| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |